Inventor
MCCALEB MICHAEL L
US18 patents
⚠️ This page may combine multiple inventors who share the name “MCCALEB MICHAEL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IONIS PHARMACEUTICALS INC
9 patentsUS9340784B2May 17, 2016
Methods and compositions for modulating alpha-1-antitrypsin expression
IONIS PHARMACEUTICALS INC11 citations84
US10280423B2May 7, 2019
Compositions and methods for modulating complement factor B expression
IONIS PHARMACEUTICALS INC10 citations83
US10426789B2Oct 1, 2019
Allele specific modulators of P23H rhodopsin
IONIS PHARMACEUTICALS INC6 citations82
US9796976B2Oct 24, 2017
Methods and compositions for modulating alpha-1 antitrypsin expression
IONIS PHARMACEUTICALS INC3 citations73
US11744846B2Sep 5, 2023
Allele specific modulators of P23H rhodopsin
IONIS PHARMACEUTICALS INC2 citations71
US11013758B2May 25, 2021
Allele specific modulators of P23H rhodopsin
IONIS PHARMACEUTICALS INC2 citations71
US9677076B2Jun 13, 2017
Modulation of hepatitis B virus (HBV) expression
IONIS PHARMACEUTICALS INC1 citations63
US11732265B2Aug 22, 2023
Compositions and methods for modulating complement factor B expression
IONIS PHARMACEUTICALS INC0 citations62
US11926830B2Mar 12, 2024
Modulators of Complement Factor B
IONIS PHARMACEUTICALS INC0 citations61
BAYER AG
5 patentsUS5965392AOct 12, 1999
Neuropeptide Y receptor Y5 and nucleic acid sequences
BAYER AG23 citations89
US5919901AJul 6, 1999
Neuropeptide Y receptor Y5 and nucleic acid sequences
BAYER AG34 citations89
US6410686B1Jun 25, 2002
Galanin receptor 2 protein
BAYER AG9 citations68
US6368824B1Apr 9, 2002
Neuropeptide Y receptor Y5 and nucleic acid sequences
BAYER AG1 citations60
US6207799B1Mar 27, 2001
Neuropeptide Y receptor Y5 and nucleic acid sequences
BAYER AG2 citations60